FRG Family Wealth Advisors’s Novo Nordisk NVO Stock Holding History

FRG Family Wealth Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$211K	Buy	+5,731	New	+$272K	0.03%	152

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

FRG Family Wealth Advisors's NVO Position: Q1 2026 in Review

FRG Family Wealth Advisors opened a new position in Novo Nordisk (NVO) in Q1 2026: 5,731 shares worth $211K. The stake represents 0.03% of the portfolio and ranks #152 among its holdings.

1,278 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

FRG Family Wealth Advisors held 5,731 shares of Novo Nordisk worth $211K as of Q1 2026.
Novo Nordisk was a new FRG Family Wealth Advisors position in Q1 2026.
Novo Nordisk made up 0.03% of FRG Family Wealth Advisors's portfolio in Q1 2026, its #152 holding.
1,278 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on FRG Family Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.